Secil Koseoglu

568 total citations
25 papers, 407 citations indexed

About

Secil Koseoglu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Secil Koseoglu has authored 25 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Hematology and 6 papers in Oncology. Recurrent topics in Secil Koseoglu's work include Platelet Disorders and Treatments (7 papers), Lipid Membrane Structure and Behavior (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Secil Koseoglu is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Lipid Membrane Structure and Behavior (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Secil Koseoglu collaborates with scholars based in United States, Canada and Germany. Secil Koseoglu's co-authors include Christy L. Haynes, Robert Flaumenhaft, Shencheng Ge, Audrey F. Meyer, Christian Peters, Philippe Bühlmann, Chun‐Ze Lai, József Rábai, Paul G. Boswell and Timothy P. Lodge and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Secil Koseoglu

25 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Secil Koseoglu United States 11 126 107 79 57 52 25 407
Alessandra Aloisi Italy 14 290 2.3× 145 1.4× 56 0.7× 22 0.4× 24 0.5× 29 631
Claudia Di Bartolomeo Italy 10 196 1.6× 31 0.3× 26 0.3× 22 0.4× 19 0.4× 15 509
Aoshuang Xu China 10 290 2.3× 58 0.5× 20 0.3× 13 0.2× 47 0.9× 29 456
Hüseyin Uysal Sweden 8 80 0.6× 17 0.2× 130 1.6× 18 0.3× 50 1.0× 9 437
Elena Motrescu Germany 10 147 1.2× 11 0.1× 22 0.3× 86 1.5× 67 1.3× 14 484
Yanru Xue China 11 254 2.0× 78 0.7× 37 0.5× 4 0.1× 8 0.2× 37 644
Nuno Neto Ireland 11 134 1.1× 29 0.3× 110 1.4× 11 0.2× 9 0.2× 23 389
Valentina Carbonaro United Kingdom 7 273 2.2× 13 0.1× 366 4.6× 16 0.3× 9 0.2× 7 690
J. Ferreira Belgium 9 259 2.1× 7 0.1× 48 0.6× 14 0.2× 14 0.3× 15 685
J. Brundell Sweden 7 205 1.6× 19 0.2× 6 0.1× 86 1.5× 99 1.9× 9 360

Countries citing papers authored by Secil Koseoglu

Since Specialization
Citations

This map shows the geographic impact of Secil Koseoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Secil Koseoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Secil Koseoglu more than expected).

Fields of papers citing papers by Secil Koseoglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Secil Koseoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Secil Koseoglu. The network helps show where Secil Koseoglu may publish in the future.

Co-authorship network of co-authors of Secil Koseoglu

This figure shows the co-authorship network connecting the top 25 collaborators of Secil Koseoglu. A scholar is included among the top collaborators of Secil Koseoglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Secil Koseoglu. Secil Koseoglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yap, Timothy A., Emiliano Calvo, Víctor Moreno, et al.. (2025). First-in-human phase I/II trial evaluating BNT142, a first-in-class mRNA encoded, bispecific antibody targeting Claudin 6 (CLDN6) and CD3, in patients (pts) with CLDN6-positive advanced solid tumors.. Journal of Clinical Oncology. 43(16_suppl). 2501–2501. 1 indexed citations
2.
Papadopoulos, Kyriakos P., Mustapha Tehfé, Albiruni Ryan Abdul Razak, et al.. (2023). A phase I/II dose escalation and expansion trial to evaluate safety and preliminary efficacy of BNT141 in patients with claudin-18.2-positive solid tumors.. Journal of Clinical Oncology. 41(16_suppl). TPS2670–TPS2670. 11 indexed citations
3.
Jacoberger-Foissac, Célia, Isabelle Cousineau, Yacine Barèche, et al.. (2022). CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer. Cancer Immunology Research. 11(1). 56–71. 46 indexed citations
4.
Hill, Jonathan A., Devapregasan Moodley, Jing Hua, et al.. (2021). 674 IL-27 signaling drives a type 1 interferon-like gene expression program of immunoregulatory pathways associated with cancer progression. Regular and Young Investigator Award Abstracts. A702–A702. 1 indexed citations
5.
Moodley, Devapregasan, Austin Dulak, Ricard Masia, et al.. (2021). Abstract 1802: CD39 inhibition shapes the transcriptional landscape of myeloid cells and induces proinflammatory states in the CT26 syngeneic tumor model. Cancer Research. 81(13_Supplement). 1802–1802. 2 indexed citations
6.
Dulak, Austin, Marc O. Johnson, Secil Koseoglu, et al.. (2020). Abstract 6639: SRF617, a potent enzymatic inhibitor of CD39, demonstrates single-agent activity and cooperates with various cancer therapies in both solid tumor and hematologic malignancies. Cancer Research. 80(16_Supplement). 6639–6639. 7 indexed citations
7.
Rausch, Matthew, Devapregasan Moodley, Secil Koseoglu, et al.. (2020). 727 Increased serum levels of EBI3 are associated with poor outcome in hepatocellular carcinoma patients and SRF388, a first-in-class IL-27 blocking antibody, inhibits the growth of murine liver tumors. SHILAP Revista de lepidopterología. A435.1–A435. 1 indexed citations
8.
Abu‐Yousif, Adnan O., Bret Bannerman, Melissa Gallery, et al.. (2018). Abstract B120: TAK-164, a GCC-targeted antibody-drug conjugate (ADC) for the treatment of colorectal cancers and other GI malignancies. Molecular Cancer Therapeutics. 17(1_Supplement). B120–B120. 7 indexed citations
9.
Meyer, Audrey F., Donghyuk Kim, Ben M. Meyer, et al.. (2017). Stereochemistry- and concentration-dependent effects of phosphatidylserine enrichment on platelet function. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1859(8). 1381–1387. 1 indexed citations
10.
11.
Koseoglu, Secil, Christian Peters, Omozuanvbo Aisiku, et al.. (2015). VAMP-7 links granule exocytosis to actin reorganization during platelet activation. Blood. 126(5). 651–660. 43 indexed citations
12.
Koseoglu, Secil, et al.. (2015). Platelet membrane variations and their effects on δ-granule secretion kinetics and aggregation spreading among different species. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(7). 1609–1618. 13 indexed citations
13.
Koseoglu, Secil & Robert Flaumenhaft. (2013). Advances in platelet granule biology. Current Opinion in Hematology. 20(5). 464–471. 50 indexed citations
14.
Meyer, Audrey F., et al.. (2013). Isotope-dilution UPLC-MS/MS determination of cell-secreted bioactive lipids. The Analyst. 138(19). 5697–5697. 3 indexed citations
15.
Koseoglu, Secil, James R. Dilks, Christian Peters, et al.. (2013). Dynamin-Related Protein-1 Controls Fusion Pore Dynamics During Platelet Granule Exocytosis. Arteriosclerosis Thrombosis and Vascular Biology. 33(3). 481–488. 33 indexed citations
16.
Koseoglu, Secil, Sara A. Love, & Christy L. Haynes. (2011). Cholesterol effects on vesicle pools in chromaffin cells revealed by carbon-fiber microelectrode amperometry. Analytical and Bioanalytical Chemistry. 400(9). 2963–2971. 19 indexed citations
17.
Kim, Donghyuk, Secil Koseoglu, Benjamin M. Manning, Audrey F. Meyer, & Christy L. Haynes. (2011). Electroanalytical Eavesdropping on Single Cell Communication. Analytical Chemistry. 83(19). 7242–7249. 30 indexed citations
18.
Flaumenhaft, Robert, Secil Koseoglu, James R. Dilks, et al.. (2011). Dynamin-Related Protein-1 Controls Fusion Pore Dynamics During Platelet Granule Secretion and Thrombus Formation In Vivo. Blood. 118(21). 361–361. 1 indexed citations
19.
Ge, Shencheng, Secil Koseoglu, & Christy L. Haynes. (2010). Bioanalytical tools for single-cell study of exocytosis. Analytical and Bioanalytical Chemistry. 397(8). 3281–3304. 45 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Aloisi Breakdown of academic impact, for papers by Claudia Di Bartolomeo Breakdown of academic impact, for papers by Aoshuang Xu Breakdown of academic impact, for papers by Hüseyin Uysal Breakdown of academic impact, for papers by Elena Motrescu Breakdown of academic impact, for papers by Yanru Xue Breakdown of academic impact, for papers by Nuno Neto Breakdown of academic impact, for papers by Valentina Carbonaro Breakdown of academic impact, for papers by J. Ferreira Breakdown of academic impact, for papers by J. Brundell
Rankless by CCL
2026